US$ 24.03
glp-1 agonist clinical trials Outcomes with Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled | Drugs Discover How GLP-1 Trials Are
Description
However, mechanisms linking the action of GIP to cardiovascular outcomes remain unclear, especially in humans, as elevated GIP was found in individuals with atherosclerotic CVD (Kahles et al

NauckMAMeierJJCavenderMAEl AzizMADruckerDJ

How bizarre is that

Wulff BS Use of GLP-peptides

10.1517/14656566.2012.642866 [DOI] [PubMed] [Google Scholar] 10.Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, et al